Related Experiment Video
Updated: Jun 16, 2025

06:08
A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
146
A Narrative Review of Artificial Intelligence in MRI-Guided Prostate Cancer Diagnosis: Addressing Key Challenges
Deniz Alis1, Aslihan Onay2, Evrim Colak3,4
1Department of Radiology, School of Medicine, Acibadem Mehmet Ali Aydinlar University, 34750 Istanbul, Atasehir, Turkey.
Diagnostics (Basel, Switzerland)
|June 13, 2025
Summary
Artificial intelligence (AI) shows promise in improving prostate cancer diagnosis using MRI, comparable to radiologists but with lower specificity. Further validation is needed for widespread clinical adoption.
Area of Science:
- Radiology
- Oncology
- Medical Imaging
Background:
- Magnetic resonance imaging (MRI) is vital for prostate cancer detection.
- Diagnostic variability exists due to patient factors, imaging protocols, and radiologist expertise.
- Artificial intelligence (AI) offers solutions to enhance diagnostic accuracy and efficiency.
Purpose of the Study:
- To review AI techniques (machine learning, deep learning) for prostate cancer diagnosis.
- To examine AI's role in improving MRI quality, artifact detection, and lesion interpretation.
- To assess AI's impact on reducing reading time and inter-reader variability.
Main Methods:
- Narrative review of AI applications in prostate cancer MRI.
- Exploration of AI for image quality enhancement and artifact detection.
- Analysis of AI's role in lesion detection, interpretation, and workflow efficiency.
Main Results:
- AI demonstrates sensitivity comparable to experienced radiologists, with potential for increased false positives due to lower specificity.
- AI effectively identifies artifacts, assesses MRI quality, and aids diagnostic efficiency.
- Generalizability of AI models is limited by variability in study methodologies and datasets.
Conclusions:
- AI holds significant promise for enhancing prostate cancer detection accuracy and efficiency.
- Challenges remain in AI model generalizability, requiring multicenter validation.
- Further development, validation, and standardization are crucial for AI's clinical integration.

